Ranalli Exam 2 Study Hub: ENT + Geriatrics + Acute/Chronic Pain
Built for select-2, matching/dropdown, sequence/order, hot spot anatomy, and those sneaky “all/none of the above” vibes. Emphasis: Ranalli-made tables, review-session pearls, NBCRNA-style high yield.
Acute Pain
Must-know pain terms
Algesia = increased sensitivity to pain
Algogenic = pain-producing substance/stimulus
Allodynia = non-harmful stimulus perceived as painful
Dysesthesia = unpleasant abnormal sensation
Hyperalgesia = heightened response to painful stimulus
Neuralgia = pain in distribution of peripheral nerve
Neuropathy = abnormal nerve function
Paresthesia = abnormal sensation, usually tingling/pins/needles
4 pain processes
Transduction: noxious stimulus → action potential at nociceptor; targets: local anesthetic/corticosteroid/NSAID
Reduced mobility → DVT/PE risk; poor cough and pulmonary toilet
Preventive/multimodal analgesia
Goal: attenuate nociceptive input before/during/after surgical insult to reduce peripheral + central sensitization
Common multimodal: local anesthetic/regional, acetaminophen, NSAID if safe, low-dose ketamine, dexmedetomidine, lidocaine infusion in selected abdominal surgery
Chronic pain patient: continue baseline pain meds when appropriate, expect tolerance/hyperalgesia, plan regional/PCA/early pain consult
Serotonin syndrome — Ranalli trap zone
Triad: neuromuscular + autonomic + mental status changes
Most important Hunter sign = clonus (spontaneous, inducible, ocular); also hyperreflexia
Hyperthermia is a big sign; severe cases → rhabdo, renal failure, DIC, ARDS
Review note: keep hyperkalemia on the differential/complication radar even if not on the chart
Common periop culprits: SSRIs/SNRIs/TCAs/MAOIs + meperidine, tramadol, fentanyl/methadone risk, linezolid, methylene blue
STOP: Stop offending agents + Supportive care; Treatment with benzodiazepines; Oxygen/intubation/paralysis/sedation if severe; Pharmacologic antidote cyproheptadine
Infrahyoid/depressors: sternohyoid, sternothyroid, thyrohyoid, omohyoid — mostly ansa cervicalis/cervical plexus with thyrohyoid via C1 hypoglossal fibers
Suprahyoid/elevators: digastric, stylohyoid, mylohyoid, geniohyoid — aid swallowing/elevate hyoid/larynx
Test angle: know “intrinsic moves cords/glottis; extrinsic moves larynx/hyoid as a unit”
Special airway equipment
RAE tube = Ring-Adair-Elwyn, not “right angled ETT”; oral RAE points down/south, nasal RAE points up/north
Armored/reinforced tubes: flexible and useful at extreme angles, oral or nasal; NOT immune to occlusion/kinking/compression
MLT = small ID/long tube for microlaryngeal work; laser tubes for airway laser
ENT principles
Shared airway: secure tube extremely well, long circuits/IV tubing, protect pressure points, communicate before turning/draping
Avoid sustained NMB when nerve monitoring/isolation required: thyroid/parathyroid/facial nerve procedures; consider NIM tube and short-acting/none after intubation
Deliberate hypotension: improves view by decreasing bleeding; goal often MAP ~60 or 20% below baseline; need patient selection, A-line/IV titration; agents include volatile, propofol, remifentanil, nitroglycerin/nitroprusside, beta-blockers, CCBs, dexmedetomidine
Avoid/limit N2O in closed spaces: tympanoplasty/middle ear graft, sinus/closed-space concerns
Volatile MAC decreases ~6% per decade after age 40; 70-year-old ≈ 18–21% decrease depending rounding
Decreased albumin → ↑ free fraction of acidic drugs like benzos/propofol-ish highly protein bound meds; alpha-1 acid glycoprotein often increased with age/inflammation affecting basic drugs
↑ body fat → larger Vd/prolonged lipophilic drugs; ↓ TBW/lean mass → smaller Vd for hydrophilic drugs
Dose low/slow; increased sensitivity to opioids, benzos, sedatives; avoid anticholinergic/Beers meds when possible